Sign Out
Clinically significant adverse reactions (Incidence unknown): Shock and anaphylaxis: Since shock or anaphylaxis (urticaria, angioedema, dyspnea, etc.) may occur, observation should be sufficiently performed. If abnormalities are observed, treatment with this product should be discontinued and appropriate measures should be taken.
Contact dermatitis: Since cutaneous symptoms such as redness, erythema, rash, itching, and pains may occur in the area to which this product is applied, the symptoms may progress to swelling, edema, blister/erosion, etc., and the symptoms may be further extended systemically, resulting in serious conditions. In such cases, treatment with this product should be discontinued and appropriate measures should be taken, if abnormalities are observed.
Other adverse reactions: See Table 1.
Click on icon to see table/diagram/image
View ADR Reporting Link
